Intellia Therapeutics Aktie
12,00
EUR
+0,62
EUR
+5,45
%
13,98
USD
-0,30
USD
-2,10
%
Werbung
Intellia Therapeutics Aktie Analyse
| 02.11.18 | Intellia Therapeutics Neutral | Wedbush Morgan Securities Inc. | |
| 15.05.18 | Intellia Therapeutics Buy | Chardan Capital Markets | |
| 28.03.17 | Intellia Therapeutics Buy | Chardan Capital Markets | |
| 31.05.16 | Intellia Therapeutics Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung